Bibliografia
2. Soler Ranzani, Lluís. Desarrollo y Evaluación Biofarmacéutica de un Sistema de Administración Transdérmica de Alprazolam. Universidad de Barcelona. Facultad de Farmacia. Barcelona España : s.n., 2006, pp: 12-34.
3. EscalonaPérez, Ernesto. DERMATOLOGIA. México, D.F. : Impresiones Modernas, 1975, pp: 9-15.
4. http://homepage.mac.com/penagoscorzo/udla/somato/piel.html.
5. Wilkes, G.L., Brown I.A., Widnaurer R.H. The Biomecanical Properties of Skin. s.l. : Cit. Rev. Bioeng, 1973, pp: 452.
6. Charlet, Egbert. Cosmética para farmacéuticos. Zaragoza, España : Acribia, 1996.7.http://web.mac.com/aloeproductos/Articulos/La_Piel/Entradas/2007/6/27_La_Epidermis.html.
8. Honeyman J., Maira M., Valdés P., Pérez P. Dermatología. Santiago, Chile : Tecnoprint Ltda, 1997; pp: 1-10.
9. http://www.msd.es/publicaciones/mmerck_hogar/seccion_18/seccion_18_199.html.
10. Arenas, Roberto. Atlas Dermatología. México : Mcgraw-Hill, 2005, pp: 1-7.
11. http://saludpasion.com/formacion-y-crecimiento-de-las-unas/.
12. Wikinson J,B. Cosmetología de Harry. Madrid, España : Días de Santos, S.A, 1990; pp: 3-17.
13. Bowden E, P y Cunliffe W, J. Modification of human prekeratin during epidermal differentiation. Great Britain : Biochemical Journal, 1988; 71: 324-329.
14. http://www.dameronline.com/capilar/infociclovital.htm.
15. Rondón Lugo, Antonio José. Dermatología. Caracas Venezuela : Industria Editorial Venezolana,1995, pp: 9-17.
16. Escobar Chávez, Jose Juan. Estudio de la penetración a travéz de la piel de naproxeno sódico utilizando agentes promotores de penetracción (azona y trancutol), y de dicluconato de clorhexidina mediante iontoforesis. Estado de México, Cuautitlan Izcalli : s.n., 2006, pp.
17. Merk, H.F., Jugert, F.K., Frankenberg, S. Biotransformations in the skin in Dermatotoxicology. USA :Taylor & Francis, 1996, pp: 61-73.
18. Saeki, M., Saito, Y., Nagano, M., Teshima, R., Ozawa, S & Sawada, J. mRNA expression of multiple cytochrome P-450 isozymes in four types of cultured. s.l. : Int Arch Allergy Immunol, 2002, 127: 333-336.
19. Villard, P.H., Sampol, E., Elkaim, J.L., Puyoou, F., Casanova, D., Seree, E., Durand,. Increase of CYP1B1 transcription in human keratinocytes.s.l. : Toxicol Appl Pharmacol, 2002, 178: 137-143.
20. Janmohamed, A., Dolphin, C.T., Phillips, I.R. & Shephard, E.A. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P-450. s.l. : Biochem Pharmacol, 2001, 62: 777-786.
21. Yengi, L.G., Xiang, Q., Pan, J., Scatina, J., Kao, J., Ball, S.E., Fruncillo, R., Ferron,.Quantitation of cytochrome P-450 mRNA levels in human skin. s.l. : Anal Biochem, 2003, 316: 103-110.
22. Gonzalez, M.C., Marteau, C., Franchi, J. & Migliore-Samour, D. Cytochrome P-450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation. s.l. : Br J Dermatol, 2001, 145: 749-757.
23. Gelardi, A., Morini, F., Dusatti, F., Penco, S. & Ferro, M. Induction byxenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. s.l. : Toxicol In Vitro, 2001, 15: 701-11.
24. Keeney, D.S., Skinner, C., Travers, J.B., Capdevila, J.H., Nanney, L.B., King, L.E. & Waterman, M.R. Differentiating keratinocytes express a novel cytochrome P-450 enzyme, CYP2B19, having arachidonate monooxygenase activity. s.l. : J Biol Chem, 1998, 273:263-280.
25. Lear, J.T., Smith, A.G., Bowers, B., Heagearty, A.H., Jones, P.W., Gilford, J., Alldersea, J., Strange, R.C. & Fryer, A.A. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P-450, CYP1A1 genotypes, and their interaction. s.l. : J Invest Dermatol, 1997, 108:519-522.
26....
Regístrate para leer el documento completo.